Sandoz Private Limited — Olaparib Exporter Profile
Indian Pharmaceutical Exporter · #2 for Olaparib · $161.9K export value · DGFT Verified
Sandoz Private Limited is the #2 Indian exporter of Olaparib with $161.9K in export value and 57 verified shipments. Sandoz Private Limited holds a 17.6% market share in Olaparib exports across 2 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.
Sandoz Private Limited — Olaparib Export Profile: Buyers & Destinations
Where Does Sandoz Private Limited Export Olaparib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SLOVENIA | $161.9K | 55 | 100.0% |
| SOUTH AFRICA | $33 | 2 | 0.0% |
Sandoz Private Limited exports Olaparib to 2 countries. The largest destination is SLOVENIA accounting for 100.0% of Sandoz Private Limited's Olaparib shipments. These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Olaparib from Sandoz Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LEK PHARMACEUTICALS D.D. | SLOVENIA | $159.9K | 50 |
| LEK PHARMACEUTICALS DD | SLOVENIA | $1.3K | 2 |
| SDC SLOVENIA | SLOVENIA | $696 | 1 |
| PIJA KOSIR | SLOVENIA | $53 | 2 |
| DSV HEALTHCARE (PTY) LIMITED | SOUTH AFRICA | $33 | 2 |
Sandoz Private Limited supplies Olaparib to 5 buyers globally. The largest buyer is LEK PHARMACEUTICALS D.D. (SLOVENIA), followed by LEK PHARMACEUTICALS DD (SLOVENIA) and SDC SLOVENIA (SLOVENIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Olaparib Export Value and How Much Does Sandoz Private Limited Contribute?
India exported $787.0K worth of Olaparib through 307 shipments from 70 suppliers to 49 countries, serving 99 buyers globally. Sandoz Private Limited contributes $161.9K to this total, accounting for 17.6% of India's Olaparib exports. Sandoz Private Limited ships Olaparib to 2 countries through 5 buyers.
What Is the Average Shipment Value for Sandoz Private Limited's Olaparib Exports?
Sandoz Private Limited's average Olaparib shipment value is $2.8K per consignment, based on 57 shipments totaling $161.9K. The largest destination is SLOVENIA (100.0% of Sandoz Private Limited's Olaparib exports).
How Does Sandoz Private Limited Compare to Other Indian Olaparib Exporters?
Sandoz Private Limited ranks #2 among 70 Indian Olaparib exporters with a 17.6% market share. The top 3 exporters are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($285.6K), SANDOZ PRIVATE LIMITED ($161.9K), VAMA HEALTH WORLD LLP ($107.6K). Sandoz Private Limited processed 57 shipments to 2 destination countries.
What Olaparib Formulations Does Sandoz Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OLAPARIB FCT 150MG B/N: 32377858 (120 TA | $20.9K | 2 |
| OLAPARIB FCT 100MG B/N: 32380402 (120 TA | $14.0K | 2 |
| OLAPARIB FCT 150MG B/N: 32378842 (120 TA | $13.4K | 2 |
| OLAPARIB FCT 150MG B/N: 32377857 (60 TAB | $12.7K | 2 |
| OLAPARIB FCT 100MG B/N: 32380489 (120 TA | $9.0K | 2 |
| OLAPARIB FCT 150MG B/N: 32376589 (120 TA | $9.0K | 2 |
| OLAPARIB FCT 100MG B/N: 32380401 (60 TAB | $8.5K | 2 |
| OLAPARIB FCT 150MG (COATED TABLETS), B/N | $6.9K | 1 |
| OLAPARIB FCT 100MG B/N: 32380165 (120 TA | $6.0K | 2 |
| OLAPARIB FCT 150MG (EXTRUDATE +BLEND), B | $5.9K | 1 |
Sandoz Private Limited exports 39 distinct Olaparib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OLAPARIB FCT 150MG B/N: 32377858 (120 TA with 2 shipments worth $20.9K.
Regulatory Requirements: Exporting Olaparib to Key Markets
What Sandoz Private Limited must comply with to export Olaparib to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sandoz Private Limited Compare to Nearest Olaparib Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $285.6K | 15 | 2 | $19.0K |
| 2 | SANDOZ PRIVATE LIMITED ★ | $161.9K | 57 | 2 | $2.8K |
| 3 | VAMA HEALTH WORLD LLP | $107.6K | 20 | 2 | $5.4K |
| 4 | SPECIALITY MEDICINES LIMITED | $76.4K | 15 | 2 | $5.1K |
Sandoz Private Limited ranks #2 among 70 Indian Olaparib exporters. Average shipment value of $2.8K compared to the market average of $11.2K. The closest competitors by value are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and VAMA HEALTH WORLD LLP.
Which Indian Ports Ship Olaparib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 120 | 39.1% |
| SAHAR AIR | 56 | 18.2% |
| HYDERABAD ACC (INHYD4) | 17 | 5.5% |
| Bombay Air Cargo | 17 | 5.5% |
| AHEMDABAD AIR ACC (INAMD4) | 16 | 5.2% |
| Bombay Air | 12 | 3.9% |
| HYDERABAD AIR | 9 | 2.9% |
| Hyderabad Air | 8 | 2.6% |
What Other Advanced Oncology Products Does Sandoz Private Limited Export?
Sandoz Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Sandoz Private Limited's Olaparib Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.
Sandoz Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.
The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.
About Sandoz Private Limited
Sandoz Private Limited exports 25 products worth $159.4M. Beyond Olaparib, top products include Tacrolimus, Apixaban, Citalopram, Escitalopram, Gabapentin. View the complete Sandoz Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Olaparib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Olaparib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 57 individual customs records matching Sandoz Private Limited exporting Olaparib, covering 39 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 49+ countries, 99+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Olaparib Export Data from Sandoz Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sandoz Private Limited's Olaparib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sandoz Private Limited
Full Company Profile →
25 products · $159.4M total trade · 15 categories
Olaparib Stats
Company Overview
Top Products by Sandoz Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sandoz Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Olaparib. For current shipment-level data, contact TransData Nexus.